STATE OF ALASKA, DEPARTMENT OF REVENUE – Regeneron Pharmaceuticals, Inc. Transaction History
STATE OF ALASKA, DEPARTMENT OF REVENUE portfolio value:
$21.86M
portfolio value
STATE OF ALASKA, DEPARTMENT OF REVENUE quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -28.84% | -12.86K shares | -4.50M | $688.87 | 31.73K |
Q2 2022 | share | Increase | +68.53% | 18.13K shares | 7.88M | $591.13 | 44.60K |
Q1 2022 | share | Increase | +15.62% | 3.57K shares | 4.02M | $698.42 | 26.46K |
Q4 2021 | share | Increase | +25.62% | 4.66K shares | 3.42M | $642.51 | 22.89K |
Q3 2021 | share | Increase | +1.12% | 202 shares | 962K | $605.18 | 18.22K |
Q2 2021 | share | Decrease | -35.49% | -9.91K shares | -3.15M | $558.54 | 18.01K |
Q1 2021 | share | Decrease | -4.69% | -1.37K shares | -942K | $473.14 | 27.93K |
Q4 2020 | share | Decrease | -4.43% | -1.35K shares | -3.00M | $483.11 | 29.30K |
Q3 2020 | share | Decrease | -15.63% | -5.68K shares | -5.50M | $559.78 | 30.66K |
Q2 2020 | share | Increase | +164.57% | 22.60K shares | 15.95M | $623.65 | 36.34K |
Q1 2020 | share | Increase | +4.61% | 605 shares | 1.77M | $488.29 | 13.73K |
Q4 2019 | share | Decrease | -7.66% | -1.09K shares | 985K | $375.48 | 13.13K |
Q3 2019 | share | Increase | +11.30% | 1.44K shares | -53K | $277.4 | 14.22K |
Q2 2019 | share | Decrease | -2.42% | -317 shares | -1.37M | $313 | 12.77K |
Q1 2019 | share | Decrease | -1.84% | -246 shares | 394K | $410.62 | 13.09K |
Q4 2018 | share | Decrease | -0.54% | -73 shares | -437K | $373.5 | 13.34K |
Q3 2018 | share | Decrease | -2.37% | -326 shares | 680K | $404.04 | 13.41K |
Q2 2018 | share | Increase | +23.90% | 2.65K shares | 921K | $344.99 | 13.74K |
Q1 2018 | share | Increase | +19.12% | 1.78K shares | 319K | $344.36 | 11.09K |
Q4 2017 | share | Increase | +638.89% | 8.05K shares | 2.93M | $375.96 | 9.31K |
Q3 2017 | share | Increase | 0.00% | 1.26K shares | 563K | $447.12 | 1.26K |